| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5592738 | Cardiovascular Revascularization Medicine | 2017 | 20 Pages |
Abstract
The late breaking trials released at the American Heart Association scientific sessions conference in November in New Orleans, LA covered a wide range of topics, including new devices within the field of heart failure, new registry data on transcatheter aortic valve replacement (TAVR) in intermediate risk patients, and medical management of peripheral arterial disease, coronary artery disease, and hypercholesterolemia. The following review highlights the late breaking trials presented at the conference that will have significant impact on clinical practice.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Kyle D. Buchanan, M. Chadi Alraies, Alexandre H. Kajita, Toby Rogers, Edward Koifman, Arie Steinvil,